TIM
BMY icon

Thor Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Thor Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3K Hold
700
– – 0.02% 51
2026
Q1 		$42.5K Buy
700
+200
+40% +$11.7K 0.02% 45
2025
Q4 		$27K Hold
500
– – 0.02% 43
2025
Q3 		$22.6K Hold
500
– – 0.01% 45
2025
Q2 		$23.1K Buy
500
+300
+150% +$14.7K 0.02% 44
2025
Q1 		$12.2K Hold
200
– – 0.01% 39
2024
Q4 		$11.3K Buy
+200
New +$11.2K 0.01% 46

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Thor Investment Management's BMY Position: Q2 2026 in Review

Thor Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, buying an estimated $147K and bringing the position to 102,446 shares worth $5.9M. The position accounts for 3.36% of the portfolio, ranked #9.

Thor Investment Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.06M in Q1 2026. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Thor Investment Management held 102,446 shares of Bristol-Myers Squibb worth $5.9M as of Q2 2026.
  • Thor Investment Management bought 2,567 Bristol-Myers Squibb shares in Q2 2026, an estimated $147K.
  • Bristol-Myers Squibb made up 3.36% of Thor Investment Management's portfolio in Q2 2026, its #9 holding.
  • Thor Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Thor Investment Management's Bristol-Myers Squibb position peaked at $6.06M in Q1 2026.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Thor Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.